Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc Stock (AMLX) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
	35.60%21.93	16.17	15.39	16.17	15.64
Selling, General, and Administrative	35.60%21.93	16.17	15.39	16.17	15.64
Research and Development	13.92%23.77	27.61	21.21	19.86	27.22
Costs And Expenses	4.37%45.69	43.78	36.61	36.03	42.86
Operating Income/Loss	4.37%-45.69	-43.78	-36.61	-36.03	-42.86
Nonoperating Income/Loss	9.02%2.27	2.50	3.65	1.64	1.41
	5.18%-43.42	-41.28	-33.00	-34.39	-41.44
Attributable To Parent	5.18%-43.42	-41.28	-33.00	-34.39	-41.44
Basic Average Shares	0.57%111.20	110.56	5.15	93.33	89.14
Diluted Average Shares	0.57%111.20	110.56	5.15	93.33	89.14
Basic Earnings Per Share	5.41%-0.39	-0.37	-0.28	-0.37	-0.46
Diluted Earnings Per Share	5.41%-0.39	-0.37	-0.28	-0.37	-0.46